SUMMARY -Ischemic heart disease (IHD) and gastroesophageal refl ux disease (GERD) are among the most common diseases worldwide, which in a considerable percentage of cases occur together, thus complicating symptoms, posing problems for timely diagnosis and hindering development of a comprehensive treatment regimen for both diseases. Research has shown that endothelial dysfunction is one of the major pathophysiological mechanisms in the development of IHD. Endothelial dysfunction also aff ects regional perfusion of the esophagus, thus compromising esophageal tissue defense mechanisms. Th e aim of our study was to investigate the role of endothelial dysfunction in the mechanisms of GERD development in patients with IHD. For the purpose of this study, we collected data on serum levels of endothelin-1, nitric oxide metabolites and lipid peroxidation products, gastric pH, parameters of regional blood fl ow, and quality of life assessment. Study results revealed that in IHD patients with concomitant GERD, endothelial dysfunction manifested by a signifi cant increase in the levels of endothelin-1 and lipid peroxidation products, with decreased levels of nitric oxide metabolites, regional blood fl ow and quality of life. Th ese fi ndings suggest that hypoxia of the esophageal mucosa, caused by endothelial dysfunction, leads to a decrease in the esophageal tissue resistance and to esophageal lower sphincter dysfunction, which, in turn, are the leading factors in the development of GERD.
Introduction
Ischemic heart disease (IHD) continues to be one of the most common diseases worldwide 1, 2 . In recent years, there has been an increasing trend in the incidence of the disease in younger people and in clinical comorbidity. One of the leading places in comorbid pathology belongs to gastroesophageal refl ux disease (GERD) 1, 3 . Research data suggest that more than onethird of patients with coronary heart disease suff er from refl ux esophagitis of varying severity while more than 60% of non-cardiac chest pain episodes in patients with IHD are associated with GERD 3, 4 . Th e concurrent presence of these diseases modifi es symptoms, aggravates clinical presentation and jeopardizes the timeliness of the correct diagnosis 2, 3 . A number of factors and mechanisms contribute to the development of such comorbidity. Shared aff erent vagal innervation of the esophagus and the heart is responsible for similarity in clinical presentations of esophageal and cardiac chest pain. Vagal innervation is also the underlying mechanism for cardiac arrhythmia and ischemia being triggered by esophageal irritation with acidic refl uxate, as well as esophageal spasm being triggered by cardiac ischemia 4, 5 . Several studies have shown that development of GERD symptoms is caused by the use of aspirin, calcium channel blockers and nitrates, medications commonly used for IHD 6, 7 . Nitrates decrease lower esophageal sphincter pressure, calcium channel blockers aff ect esophageal motility slowing peristalsis, and aspirin is an esophageal and gastric mucosa irritant. All these drug-related mechanisms contribute to the development of GERD in patients with IHD. Substantial research data suggest that endothelial dysfunction is the leading mechanism in the pathogenesis of IHD. With regard to the esophagus, endothelial dysfunction aff ects regional blood circulation causing tissue hypoxia, thus decreasing esophageal tissue resistance and its ability to withstand acidic refl uxate [8] [9] [10] [11] . Based on this, the purpose of the present study was to investigate the role of endothelial dysfunction in the mechanisms of development of GERD in patients with IHD.
Subjects and Methods
Th e present study was conducted in a total of 105 adult subjects divided into three groups. Group 1 included 45 adults (30 women and 15 men) aged 35 to 45 years with angina pectoris I-II functional class comorbid with non-erosive form of GERD. Th e diagnosis of IHD was based on ICD-10 classifi cation, while the diagnosis of GERD was based on ICD- 10 Endothelial function assessment was performed by measurement of serum levels of endothelin-1, nitric oxide (NO) metabolites and lipid peroxidation products. Endothelin-1 level was measured using commercially available Endothelin-1 ELISA System kit, according to the manufacturer's protocol (Amersham Pharmacia Biotech, UK). Levels of stable NO metabolites (NO2 blood and NO2 + NO3 blood) was determined by spectrometry (Griess-Ilosvaya method). Quantifi cation of the lipid peroxidation products was performed by measuring levels of serum thiobarbituric acid-reactive substances (TBARS) using a commercially available ELISA kit, according to the manufacturer's protocol (HBO REAKOMPLEKS, Russia).
Gastric secretory function was assessed by endogastric pH-metry with ML-2 unit (production of Ukraine).
Th e 12-lead baseline electrocardiography (ECG) was performed according to standard procedures on the UCARD-200 unit (production of Russia).
Th e state of the regional blood circulation was assessed by measurement of blood fl ow velocity and celiac trunk diameter. Th ese parameters were determined using sonography with color Doppler mapping performed on an Aloka-SSD-650 ultrasound apparatus (production of Japan).
Patient quality of life was assessed by using the SF-36 questionnaire.
Statistical data processing was carried out by the methods of variation and parametric statistics for biomedical research using Excel for Windows and Statistica 6.0 software.
Results and Discussion
Th e mean values of endothelin-1 levels were as follows: 8.3±0.57 pmol/L in group 1 patients (IHD + GERD) and 4.1±0.23 pmol/L in group 2 patients (GERD), indicating signifi cant increase in comparison with normal values of 1.92±0.23 pmol/L. Th e levels of endothelin-1 in control group were within the normal limits.
Th e mean levels of stable NO metabolites were as follows: group 1, NO2 Th ere were apparent diff erences in the results between the study groups. Group 1 patients had a statistically signifi cant (p<0.001) increase in endothelin-1 levels and decrease in the levels of stable NO metabolites as compared with group 2 and control group. Group 2 patients showed a statistically signifi cant increase in the levels of endothelin-1 and decrease in the levels of stable NO metabolites compared with control group, but deviation from the normal values was signifi cantly lower than in group 1 patients. Furthermore, in group 1, deviation from the normal levels of endothelin-1 (increase) was more pronounced than changes in the levels of NO metabolites (decrease), while deviations from the normal levels of those biomarkers in group 2 patients were comparable.
Th e mean level of TBARS was 11.81±0.62 μmol /L in group 1 and 15.25±0.74 μmol/L in group 2, indicating signifi cant increase as compared with normal levels of 4.5±0.35 μmol/L. On group comparison, group 2 patients had signifi cantly higher levels of lipid peroxidation products than both group 1 and control group.
Assessment of the regional blood circulation revealed a statistically signifi cant reduction in the celiac trunk diameter and decrease in blood fl ow velocity in the celiac trunk in both groups 1 and 2 as compared with normal values of 0.99±0.14 cm for celiac trunk diameter and 14.4±0.9 cm/s for blood fl ow velocity. Th e mean values of celiac trunk diameter were 0.7±0.1 cm in group 1 and 0.88±0.12 cm in group 2. Th e mean blood fl ow velocity measured 7.8±0.5 cm/s in group 1 and 10.3±0.6 cm/s in group 2. In group 1 patients, decrease in the celiac trunk diameter prevailed over decrease in blood fl ow velocity in its signifi cance. Group comparison showed the decrease in the values of celiac trunk diameter and blood fl ow velocity in group 2 patients to be apparent in comparison with control group, but less signifi cant than in group 1 patients.
Gastric pH was measured in the body of the stomach, with pH 1.7±0.2 being considered a normal value. Th e mean value of gastric pH was 1.3±0.1 in group 1 and 1.1±0.1 in group 2. Such a decrease in pH values indicated increase in gastric acidity, which was significantly greater in group 2 patients in comparison with both the control group and group 1 patients. Th e study revealed a signifi cant decrease in the quality of life indicators in all main domains of the SF-36 scale for both patient groups as compared with the control group (p<0.001). Moreover, in patients with IHD and concomitant GERD, severe decline was recorded in the general health and social functioning scales, which amounted to 42.3±4.5 points and 51.2±4.4 points, respectively (normal, 77.8±5.1 points and 85.3±4.6 points, respectively). At the same time, in patients with GERD without comorbidity, the scores were 55.9±3.7 and 68.2±3.3 points, respectively. Th us, according to the results, the indicators were significantly higher in group 2 than in control group (p<0.001), but signifi cantly lower than in group 1. At the same time, the indicators of pain intensity scales, role and physical functioning were signifi cantly higher in group 2, with the mean values of 35.4±3.7 and 33.2±2.8 points, respectively (normal, 75.7±4.2; 73.8±3.2 points) as compared with control group and group 1 (48.4±4.5; 49.7±3.8 points).
In both patient groups, there was strong correlation (group 1, r=0.76; group 2, r=0.70) between the quality of life scores and study variables, i.e. levels of endothelin-1, NO metabolites, lipid peroxidation products, parameters of regional blood fl ow, and gastric pH. Study results suggest that endothelial dysfunction plays one of the leading roles in the development of GERD in IHD patients. Endothelial dysfunction is evidenced by a signifi cant increase in the levels of endothelin-1 and decrease in the levels of NO metabolites and parameters of regional blood fl ow in celiac trunk, which reduces esophageal tissue resistance and results in the lower esophageal sphincter dysfunction. In GERD patients without concomitant pathology, stress evidenced by increase in the quality of life indicators (intensity of pain, role and physical functioning) triggers an increased production of hydrochloric acid in the stomach and elevation of endothelin-1 levels. Th is, in turn, leads to a decrease in regional blood fl ow and tissue hypoxia, resulting in higher rates of lipid peroxidation products, and reduced esophageal tone and motility, and helps maintain the increased production of hydrochloric acid. It may be extrapolated that endothelial dysfunction is one of the major mechanisms that triggers the development of GERD in IHD patients. Besides, in patients with isolated GERD, endothelial dysfunction can develop as a sec-ondary pathology, aggravating the clinical course of the disease. Th e study fi ndings suggest that in IHD patients with concomitant GERD, the anti-refl ux barrier dysfunction at the esophagogastric junction occurs due to reduced esophageal tissue defense mechanisms resulting from perfusion-related tissue hypoxia, whereas in GERD patients without comorbidity, anti-refl ux barrier dysfunction is induced by the increased corrosive properties of refl uxate. Study results pointed to the need for a diff erentiated approach to treatment based on the specifi c role endothelial dysfunction plays in the pathophysiology of both diseases.
Conclusions

Patients with IHD and concomitant GERD
have a signifi cant decrease in the quality of life parameters on all scales compared with control group, and in the general health and social functioning indicators, signifi cantly higher than in GERD patients without comorbidity. In patients with isolated GERD, the study demonstrated a signifi cant increase in pain, physical functioning and role-playing indicators compared with normal values and group 1 patients. 2. Patients with IHD and concomitant GERD showed a statistically signifi cant increase in endothelin-1 levels and decrease in the levels of stable NO metabolites as compared with GERD patients without comorbidity and control group. 3. Patients with GERD without comorbidity had distinct reduction in the values of celiac trunk diameter and blood fl ow velocity in comparison with control group, but less signifi cant than in IHD patients with concomitant GERD. 4. Increase in the levels of lipid peroxidation products and increased gastric juice acidity in IHD patients with concomitant GERD was apparent as compared with control group, but less signifi cant than in GERD patients without comorbidity. 5. Th e fi ndings suggest that endothelial dysfunction in IHD patients with concomitant GERD aff ects esophageal tissue defense mechanisms precipitating anti-refl ux barrier dysfunction at the esophagogastric junction, while in GERD patients without comorbidity it potentiates corrosive properties of refl uxate. Results of the study will contribute to more extensive detection of endothelial dysfunction in patients with IHD accompanied by GERD. In addition, these results will be used to develop methods for preventing development of GERD in patients with IHD.
